Comparison of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism, Immunohistochemistry, and DNA Sequencing for the Detection of IDH1 Mutations in Gliomas

IDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation. However, this technology is not available in most neuropathological centers in developing countries such as Indonesia. Immunohistochemistry (...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Asian Pacific journal of cancer prevention : APJCP Ročník 21; číslo 11; s. 3229 - 3234
Hlavní autori: Malueka, Rusdy Ghazali, Theresia, Emilia, Fitria, Fitria, Argo, Ibnu Widya, Donurizki, Aditya Dwi, Shaleh, Sabillal, Innayah, Meutia Rizki, Wicaksono, Adiguno Suryo, Dananjoyo, Kusumo, Asmedi, Ahmad, Hartanto, Rachmat Andi, Dwianingsih, Ery Kus
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Thailand West Asia Organization for Cancer Prevention 01.11.2020
Predmet:
ISSN:2476-762X, 1513-7368, 2476-762X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract IDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation. However, this technology is not available in most neuropathological centers in developing countries such as Indonesia. Immunohistochemistry (IHC) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) have also been used to detect IDH1 mutation. This study aimed to compare DNA sequencing, IHC, and PCR-RFLP in detecting IDH1 mutations in gliomas. Research subjects were recruited from Dr. Sardjito Hospital. Genomic DNA was extracted from fresh or formalin-fixed paraffin-embedded samples of tumor tissue. DNA sequencing, PCR-RFLP and IHC were performed to detect IDH1 mutation. Sensitivity, specificity, and accuracy of PCR-RFLP and IHC were calculated by comparing them to DNA sequencing as the gold standard. Among 61 recruited patients, 13 (21.3%) of them carried a mutation in codon 132 of the IDH1 gene, as shown by DNA sequencing. PCR-RFLP and DNA sequencing have a concordance value of 100%. Meanwhile, the concordance value between IDH1 R132H IHC and DNA sequencing was 96.7%. The sensitivity, specificity, positive predictive values, negative predictive values, and accuracy for PCR-RFLP were all 100%. On the other hand, the sensitivity, specificity, and accuracy of IHC were 92.3%, 97.9%, and 96.7%, respectively. This study showed that both PCR-RFLP and IHC have high accuracy in detecting IDH1 mutation. We recommend a combination of PCR-RFLP and IHC to detect IDH1 mutation in resource-limited settings. .
AbstractList IDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation. However, this technology is not available in most neuropathological centers in developing countries such as Indonesia. Immunohistochemistry (IHC) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) have also been used to detect IDH1 mutation. This study aimed to compare DNA sequencing, IHC, and PCR-RFLP in detecting IDH1 mutations in gliomas. Research subjects were recruited from Dr. Sardjito Hospital. Genomic DNA was extracted from fresh or formalin-fixed paraffin-embedded samples of tumor tissue. DNA sequencing, PCR-RFLP and IHC were performed to detect IDH1 mutation. Sensitivity, specificity, and accuracy of PCR-RFLP and IHC were calculated by comparing them to DNA sequencing as the gold standard. Among 61 recruited patients, 13 (21.3%) of them carried a mutation in codon 132 of the IDH1 gene, as shown by DNA sequencing. PCR-RFLP and DNA sequencing have a concordance value of 100%. Meanwhile, the concordance value between IDH1 R132H IHC and DNA sequencing was 96.7%. The sensitivity, specificity, positive predictive values, negative predictive values, and accuracy for PCR-RFLP were all 100%. On the other hand, the sensitivity, specificity, and accuracy of IHC were 92.3%, 97.9%, and 96.7%, respectively. This study showed that both PCR-RFLP and IHC have high accuracy in detecting IDH1 mutation. We recommend a combination of PCR-RFLP and IHC to detect IDH1 mutation in resource-limited settings. .
IDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation. However, this technology is not available in most neuropathological centers in developing countries such as Indonesia. Immunohistochemistry (IHC) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) have also been used to detect IDH1 mutation. This study aimed to compare DNA sequencing, IHC, and PCR-RFLP in detecting IDH1 mutations in gliomas.BACKGROUNDIDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation. However, this technology is not available in most neuropathological centers in developing countries such as Indonesia. Immunohistochemistry (IHC) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) have also been used to detect IDH1 mutation. This study aimed to compare DNA sequencing, IHC, and PCR-RFLP in detecting IDH1 mutations in gliomas.Research subjects were recruited from Dr. Sardjito Hospital. Genomic DNA was extracted from fresh or formalin-fixed paraffin-embedded samples of tumor tissue. DNA sequencing, PCR-RFLP and IHC were performed to detect IDH1 mutation. Sensitivity, specificity, and accuracy of PCR-RFLP and IHC were calculated by comparing them to DNA sequencing as the gold standard.METHODSResearch subjects were recruited from Dr. Sardjito Hospital. Genomic DNA was extracted from fresh or formalin-fixed paraffin-embedded samples of tumor tissue. DNA sequencing, PCR-RFLP and IHC were performed to detect IDH1 mutation. Sensitivity, specificity, and accuracy of PCR-RFLP and IHC were calculated by comparing them to DNA sequencing as the gold standard.Among 61 recruited patients, 13 (21.3%) of them carried a mutation in codon 132 of the IDH1 gene, as shown by DNA sequencing. PCR-RFLP and DNA sequencing have a concordance value of 100%. Meanwhile, the concordance value between IDH1 R132H IHC and DNA sequencing was 96.7%. The sensitivity, specificity, positive predictive values, negative predictive values, and accuracy for PCR-RFLP were all 100%. On the other hand, the sensitivity, specificity, and accuracy of IHC were 92.3%, 97.9%, and 96.7%, respectively.RESULTSAmong 61 recruited patients, 13 (21.3%) of them carried a mutation in codon 132 of the IDH1 gene, as shown by DNA sequencing. PCR-RFLP and DNA sequencing have a concordance value of 100%. Meanwhile, the concordance value between IDH1 R132H IHC and DNA sequencing was 96.7%. The sensitivity, specificity, positive predictive values, negative predictive values, and accuracy for PCR-RFLP were all 100%. On the other hand, the sensitivity, specificity, and accuracy of IHC were 92.3%, 97.9%, and 96.7%, respectively.This study showed that both PCR-RFLP and IHC have high accuracy in detecting IDH1 mutation. We recommend a combination of PCR-RFLP and IHC to detect IDH1 mutation in resource-limited settings. .CONCLUSIONThis study showed that both PCR-RFLP and IHC have high accuracy in detecting IDH1 mutation. We recommend a combination of PCR-RFLP and IHC to detect IDH1 mutation in resource-limited settings. .
Author Dananjoyo, Kusumo
Asmedi, Ahmad
Hartanto, Rachmat Andi
Fitria, Fitria
Dwianingsih, Ery Kus
Innayah, Meutia Rizki
Wicaksono, Adiguno Suryo
Donurizki, Aditya Dwi
Theresia, Emilia
Argo, Ibnu Widya
Shaleh, Sabillal
Malueka, Rusdy Ghazali
AuthorAffiliation 2 Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
3 Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
1 Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
AuthorAffiliation_xml – name: 1 Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– name: 3 Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– name: 2 Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
Author_xml – sequence: 1
  givenname: Rusdy Ghazali
  surname: Malueka
  fullname: Malueka, Rusdy Ghazali
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 2
  givenname: Emilia
  surname: Theresia
  fullname: Theresia, Emilia
  organization: Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 3
  givenname: Fitria
  surname: Fitria
  fullname: Fitria, Fitria
  organization: Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 4
  givenname: Ibnu Widya
  surname: Argo
  fullname: Argo, Ibnu Widya
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 5
  givenname: Aditya Dwi
  surname: Donurizki
  fullname: Donurizki, Aditya Dwi
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 6
  givenname: Sabillal
  surname: Shaleh
  fullname: Shaleh, Sabillal
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 7
  givenname: Meutia Rizki
  surname: Innayah
  fullname: Innayah, Meutia Rizki
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 8
  givenname: Adiguno Suryo
  surname: Wicaksono
  fullname: Wicaksono, Adiguno Suryo
  organization: Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 9
  givenname: Kusumo
  surname: Dananjoyo
  fullname: Dananjoyo, Kusumo
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 10
  givenname: Ahmad
  surname: Asmedi
  fullname: Asmedi, Ahmad
  organization: Department of Neurology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 11
  givenname: Rachmat Andi
  surname: Hartanto
  fullname: Hartanto, Rachmat Andi
  organization: Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
– sequence: 12
  givenname: Ery Kus
  surname: Dwianingsih
  fullname: Dwianingsih, Ery Kus
  organization: Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito General Hospital, Yogyakarta, Indonesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33247679$$D View this record in MEDLINE/PubMed
BookMark eNpVUdtu1DAQtVARvcAvVH7koUljO7HjF6RVlraLFlgVkHiLvMl4YxTbi50g7Sfxl3XZgsrTHM3lnDMz5-jEeQcIXZIiZ6SqxPVi86HZ5LSgRU5JTkjOKJUv0BktBc8Ep99PnuFTdB7jj6Ioq1pUr9ApY48lIc_Q78bbvQomeoe9xhs_HiwEFQE3gzIO34PqJuNddg9xCuYPxjdB7Sy4Ca_B7abhOOXDfjDRXuGVtbPzCU--G8CmGA5XWLkeLz8t8Bf4OYPrjNth7QOeBsBLmOBInByslncEf5wn9ZiIOFm4HY23Kr5GL7UaI7x5ihfo2837r81dtv58u2oW66xjVMqsrPuSKCFrKSnt9VbXBeNbwSjXvATNOuBdVwvNiOhlpYjkBQime6hrRdS2Zhfo3ZF3P28t9F3aM6ix3QdjVTi0Xpn2_4ozQ7vzv9okxAjjieDtE0Hwadc4tekGHYyjcuDn2NKSV2VZSlal1svnWv9E_v6HPQADi5oh
CitedBy_id crossref_primary_10_1007_s10278_025_01580_w
crossref_primary_10_1007_s00432_022_04336_z
crossref_primary_10_1007_s40291_022_00638_7
crossref_primary_10_1097_MNM_0000000000001449
crossref_primary_10_12688_f1000research_110726_1
ContentType Journal Article
DBID NPM
7X8
5PM
DOI 10.31557/APJCP.2020.21.11.3229
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2476-762X
EndPage 3234
ExternalDocumentID PMC8033136
33247679
Genre Journal Article
GroupedDBID NPM
7X8
---
23N
2WC
53G
5GY
5PM
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
E3Z
EBS
EJD
F5P
FRJ
GROUPED_DOAJ
GX1
HYE
JDI
OK1
OVT
RPM
TR2
W2D
WOW
ID FETCH-LOGICAL-c3299-48d41a7989922dfbf8036b7326f64ef3ce6cc87f317d95a1960e73fde88a1ab83
ISSN 2476-762X
1513-7368
IngestDate Tue Nov 04 02:00:37 EST 2025
Thu Jul 10 19:12:22 EDT 2025
Thu Jan 02 22:57:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords immunuhistochemistry
PCR–RFLP
Glioma
IDH1 gene
DNA Sequencing
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3299-48d41a7989922dfbf8036b7326f64ef3ce6cc87f317d95a1960e73fde88a1ab83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://dx.doi.org/10.31557/APJCP.2020.21.11.3229
PMID 33247679
PQID 2465444935
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8033136
proquest_miscellaneous_2465444935
pubmed_primary_33247679
PublicationCentury 2000
PublicationDate 20201101
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 20201101
  day: 1
PublicationDecade 2020
PublicationPlace Thailand
PublicationPlace_xml – name: Thailand
– name: Iran
PublicationTitle Asian Pacific journal of cancer prevention : APJCP
PublicationTitleAlternate Asian Pac J Cancer Prev
PublicationYear 2020
Publisher West Asia Organization for Cancer Prevention
Publisher_xml – name: West Asia Organization for Cancer Prevention
SSID ssj0045875
Score 2.2918248
Snippet IDH1 mutation shows diagnostic, prognostic, and predictive value in gliomas. Direct Sanger sequencing is considered the gold standard to detect IDH1 mutation....
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 3229
Title Comparison of Polymerase Chain Reaction-Restriction Fragment Length Polymorphism, Immunohistochemistry, and DNA Sequencing for the Detection of IDH1 Mutations in Gliomas
URI https://www.ncbi.nlm.nih.gov/pubmed/33247679
https://www.proquest.com/docview/2465444935
https://pubmed.ncbi.nlm.nih.gov/PMC8033136
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals (ODIN)
  customDbUrl:
  eissn: 2476-762X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0045875
  issn: 2476-762X
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9owELaWbbXaS9V36WPlSr2xoSQ2cXxcwb6qglC1lVAvyEkciMoGxGO19NT_0J_Rf9Vf0rEdJ2HFoa3USxQFAuOMP8948s0MQu_AE_JFK0ycNmWhQ8OQOAGVniN4WwZBLFtMUN1sgvX7wXDIB3u1LzYX5mbKsiy4veXz_6pquAbKVqmzf6Hu4kfhApyD0uEIaofjHym-U-0sqPhtGxV3Wkr1Zj1V8XqTymBZDuSTVK07TMdwcGPHmh3wUWbj1cTcPQNVKH6GWk1UNslM1yiObKc4y__s9k9g5dHEbMvOVE5tV65kZN3Sy-6F2-itVyWD_XyaFgwlWwxX53XmbMFqaYtIzdCFKmtgSZo6rDn40CmS1HpiupZfjUO8XsabxvlEfIOtRsl_kQu5NATh0-t0mhZW6SxVDUy0L6_PSiSMdTT5MszWsIbGG1ENlMCu2N0KlKhOPQ01gq0sV_00Okb8QSF-1SC4xGHEtP5pSn3No8x3wIgMq1bE5HlbtLgVmwBLJq_4F8Qz0du7touAZ6den-un1lQDaHouWLSmvb8yd-fXevISokRhvLTlBcNy0OsELUJc4tfQPY-1ObfhBuOl0Hagi1AX4zPZ81qI9ztFOEQH9v927cbukoorXtrVQ_Qg317hEwOLR2hPZo_RQS8nkDxBP0t04FmCS3RgjQ5s0fHr-48KLrDFBTa4wFVcHONdqDjGgAkMmMAlJjDMAgyYwAUmlAwKE7jABAYhckw8RZ_PTq86F07er8SJCHh1Dg1i6grGA1XrOU7CBDTghww2SIlPZUIi6UdRwBJw2WPeFmD7WpKRJIZFUbgiDMgztJ_NMvkC4YSwyJNei8fEpZ4bcy59QV0uwjjmScTq6K3VwAiGpV7yiUzO1suRpwokUspJu46eG42M5qZwzcjqr47Ylq6KL6ha89ufZOlE15zPJ9PLf77zFTosQfka7a8Wa_kG3Y9uVulycYRqbBgc6RkKx_6g9xt1SwMc
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Polymerase+Chain+Reaction%E2%80%93Restriction+Fragment+Length+Polymorphism%2C+Immunohistochemistry%2C+and+DNA+Sequencing+for+the+Detection+of+IDH1+Mutations+in+Gliomas&rft.jtitle=Asian+Pacific+journal+of+cancer+prevention+%3A+APJCP&rft.au=Malueka%2C+Rusdy+Ghazali&rft.au=Theresia%2C+Emilia&rft.au=Fitria%2C+Fitria&rft.au=Argo%2C+Ibnu+Widya&rft.date=2020-11-01&rft.pub=West+Asia+Organization+for+Cancer+Prevention&rft.issn=1513-7368&rft.eissn=2476-762X&rft.volume=21&rft.issue=11&rft.spage=3229&rft.epage=3234&rft_id=info:doi/10.31557%2FAPJCP.2020.21.11.3229&rft_id=info%3Apmid%2F33247679&rft.externalDocID=PMC8033136
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2476-762X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2476-762X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2476-762X&client=summon